Topspin Partners logo

Topspin Partners

North America, New York, United States, Mamaroneck

Description

Topspin Partners is a Mamaroneck, New York-based private equity firm with a history rooted in venture capital. Formed in 2000, it succeeded the Long Island Venture Fund, which began its investment activities in 1995. While its origins are in early-stage investing, Topspin Partners has evolved into a middle-market private equity firm, primarily focused on making control investments. This distinction is crucial, as their current strategy involves acquiring significant stakes in established companies rather than providing seed or early-stage venture capital.

The firm's investment strategy targets companies within the consumer, health & wellness, and related business services sectors. Topspin seeks businesses with strong fundamentals, proven management teams, and significant growth potential. They typically look for companies generating between $3 million and $15 million in EBITDA, indicating a focus on profitable, mature businesses rather than nascent startups. Their approach involves partnering with management to implement operational improvements and strategic initiatives aimed at accelerating growth and enhancing value.

Topspin Partners typically deploys substantial equity capital in its transactions. For each investment, the firm aims to commit between $15 million and $50 million of equity. This capital is used to facilitate buyouts, recapitalizations, and growth equity investments, always with the goal of achieving a controlling interest. The firm emphasizes a hands-on approach, leveraging its team's operational expertise to support portfolio companies through various stages of development, from strategic planning to market expansion and operational efficiency improvements. Their long-standing presence in the market, originating from a fund established over two decades ago, underscores their experience in private market investments.

Investor Profile

Topspin Partners has backed more than 48 startups, with 0 new investments in the last 12 months alone. The firm has led 16 rounds, about 33% of its total and boasts 15 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Typical check size: $15M – $50M.

Stage Focus

  • Series C (23%)
  • Series B (19%)
  • Series Unknown (15%)
  • Series D (10%)
  • Series A (10%)
  • Series E (8%)
  • Private Equity (6%)
  • Series F (4%)
  • Seed (2%)
  • Pre Seed (2%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Genetics
  • Biopharma
  • Manufacturing
  • Analytics
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Topspin Partners frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 8
EC
North America, New York, United States, New York
Co-Investments: 3
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 3
Boston Scientific
North America, Massachusetts, United States, Marlborough
Co-Investments: 3
NGEN Partners
North America, New York, United States, New York
Co-Investments: 3
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 3
The Column Group
North America, California, United States, San Francisco
Co-Investments: 11
Morgenthaler Ventures
North America, California, United States, Menlo Park
Co-Investments: 3
Solon Mack Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 3
Action Potential Venture Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 3

Which angels does Topspin Partners often collaborate with?

JT
North America, California, United States, San Francisco
Shared Deals: 1
EM
North America, California, United States, Los Angeles
Shared Deals: 1

What are some of recent deals done by Topspin Partners?

Mission Product Holdings

New York, New York, United States

Mission Product Holdings is a manufacturing firm that designs and provides wearable cooling solutions.

Consumer GoodsFashionProduct DesignRetailSporting GoodsSports
Private EquityJan 11, 2022
Coop Home Goods

Pico Rivera, California, United States

Coop offers adjustable sleep products.

CommercialConsumer GoodsWholesale
Private EquityAug 17, 2021
SportPet

Waukesha, Wisconsin, United States

SportPet is a seasoned manufacturer and marketer of branded and private label pet products.

ManufacturingPet
Private EquityAug 10, 2021
reCommerce

Florida, New York, United States

reCommerce is a full-service brand agency that assists international brands in optimizing their Amazon presence and increasing sales.

AdvertisingE-Commerce
Series UnknownMay 28, 2020
Codagenix

Farmingdale, New York, United States

Codagenix develops live-attenuated viral vaccines to provide target antigens placed in an attenuated backbone virus.

BiotechnologyGeneticsMedical
Series BJan 13, 2020
Amount Raised: $20,000,000
PMV Pharmaceuticals

Redwood City, California, United States

PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.

BiopharmaBiotechnologyHealth CareMedical Device
Series CNov 13, 2019
Amount Raised: $62,000,000
SetPoint Medical

Valencia, California, United States

SetPoint Medical develops novel therapeutics for the treatment of chronic autoimmune conditions.

BiotechnologyHealth CareMedicalTherapeutics
Series UnknownSep 18, 2019
Amount Raised: $15,700,000
ORIC Pharmaceuticals

South San Francisco, California, United States

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Series DAug 9, 2019
Amount Raised: $55,000,000
Rapt Therapeutics

South San Francisco, California, United States

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Series CJun 19, 2019
Amount Raised: $37,000,000
Celmatix

New York, New York, United States

Celmatix is a preclinical-stage biotech transforming women's lives through better ovarian health.

BiotechnologyHealth CarePharmaceutical
Series UnknownApr 1, 2019
Amount Raised: $6,500,000